Menu
14/06/2004
NHS plan set to end cancer drug 'postcode lottery'
The government has set out plans to tackle the 'postcode lottery' over access to treatment including cancer drugs.
A report by the National Cancer Director, Professor Mike Richards, shows "unacceptably high" variations across the country in the uptake of cancer drugs approved by the National Institute for Clinical Excellence (NICE). NICE makes recommendations on treatments and care using the best available evidence.
Health Secretary John Reid said: "Mike Richards' report today highlights one area where we need to act - and I am determined to ensure patients across the country have access to drugs which can help them."
Mr Reid said that the government was today setting out detailed plans for ensuring that recommendations from NICE are adopted by the NHS across the country.
He added that the local NHS will be asked to set out their plans for improvement in the areas highlighted in Professor Richards' report.
"The steps we are announcing today mean we will have better access to prescribing information much more quickly than planned," he said.
"I am confident we will be able to use this data to improve the uptake of these important drugs, while ensuring clinicians retain the final say in the treatment of individual patients."
(gmcg)
A report by the National Cancer Director, Professor Mike Richards, shows "unacceptably high" variations across the country in the uptake of cancer drugs approved by the National Institute for Clinical Excellence (NICE). NICE makes recommendations on treatments and care using the best available evidence.
Health Secretary John Reid said: "Mike Richards' report today highlights one area where we need to act - and I am determined to ensure patients across the country have access to drugs which can help them."
Mr Reid said that the government was today setting out detailed plans for ensuring that recommendations from NICE are adopted by the NHS across the country.
He added that the local NHS will be asked to set out their plans for improvement in the areas highlighted in Professor Richards' report.
"The steps we are announcing today mean we will have better access to prescribing information much more quickly than planned," he said.
"I am confident we will be able to use this data to improve the uptake of these important drugs, while ensuring clinicians retain the final say in the treatment of individual patients."
(gmcg)
Related UK National News Stories
Click here for the latest headlines.
17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
24 May 2005
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
13 June 2008
'Denied' Cancer Drug Now Available
A costly cancer drug that could have prolonged the life of a patient is now being made widely available in the UK. However, it is too late for charity-fund raiser, Jane Tomlinson, 43, who passed away last September. She was denied the drug, Lapatinib, because her NHS trust would not pay the £6,700 cost.
'Denied' Cancer Drug Now Available
A costly cancer drug that could have prolonged the life of a patient is now being made widely available in the UK. However, it is too late for charity-fund raiser, Jane Tomlinson, 43, who passed away last September. She was denied the drug, Lapatinib, because her NHS trust would not pay the £6,700 cost.
29 July 2010
£50M Fund For Cancer Drugs Announced
Cancer patients are set to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund, the government has announced.
£50M Fund For Cancer Drugs Announced
Cancer patients are set to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund, the government has announced.
25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
-
Northern Ireland WeatherThis Evening and Tonight:A band of heavier rain will move east during the evening before clearing eastwards after midnight. then mostly dry through the early hours, but a little rain towards dawn. Minimum temperature 9 °C.
